# Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression

> **NCT06760923** · — · RECRUITING · sponsor: **Xiangya Hospital of Central South University** · enrollment: 240 (estimated)

## Conditions studied

- Ovarian Cancer (OvCa)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06760923
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06760923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06760923, "Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06760923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*